Found: 2
Select item for more details and to access through your institution.
MDM4 is a rational target for treating breast cancers with mutant p53.
- Published in:
- Journal of Pathology, 2017, v. 241, n. 5, p. 661, doi. 10.1002/path.4877
- By:
- Publication type:
- Article
Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53.
- Published in:
- Journal of Pathology, 2014, v. 233, n. 4, p. 415, doi. 10.1002/path.4378
- By:
- Publication type:
- Article